RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD-Reference-Cited by-同舟云学术

RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD

Published:2020-10-15 Issue:4 Volume:76 Page:1123-1135
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Allam Venkata Sita Rama Raju¹,Faiz Alen²³⁴,Lam Maggie⁵,Rathnayake Senani N. H.²,Ditz Benedikt³,Pouwels Simon D.³⁴,Brandsma Corry‐Anke⁴⁶,Timens Wim⁴⁶,Hiemstra Pieter S.⁷,Tew Gaik W.⁸,Neighbors Margaret⁸,Grimbaldeston Michele⁸,van den Berge Maarten³,Donnelly Sheila²,Phipps Simon⁹,Bourke Jane E.⁵,Sukkar Maria B.¹^ORCID

Affiliation:

1. Graduate School of Health Faculty of Health The University of Technology Sydney Ultimo NSW Australia

2. School of Life Sciences Faculty of Science The University of Technology Sydney Ultimo NSW Australia

3. Department of Pulmonary Diseases University of Groningen University Medical Center Groningen Groningen The Netherlands

4. Department of Pathology and Medical Biology University of Groningen University Medical Center Groningen Groningen The Netherlands

5. Biomedicine Discovery Institute and Department of Pharmacology School of Biomedical Sciences Monash University Melbourne Vic. Australia

6. Groningen Research Institute for Asthma and COPD University of Groningen University Medical Center Groningen Groningen The Netherlands

7. Department of Pulmonology Leiden University Medical Center Leiden The Netherlands

8. OMNI‐Biomarker Development, Genentech Inc South San Francisco CA USA

9. QIMR Berghofer Medical Research Institute Herston Qld Australia

Funder

Thoracic Society of Australia and New Zealand

Universitair Medisch Centrum Groningen

Genentech

Lung Foundation Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14563

Reference58 articles.

1. Risk factors and early origins of chronic obstructive pulmonary disease

2. RAGE: a new frontier in chronic airways disease

3. Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung

4. Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review

5. Expression of High-Mobility Group Box 1 and of Receptor for Advanced Glycation End Products in Chronic Obstructive Pulmonary Disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low serum double-stranded DNA levels are associated with higher survival rates in severe COPD patients;ERJ Open Research;2024-05-29

2. The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases;Biomolecules;2024-03-28

3. Toll-like receptor 4: A potential therapeutic target for multiple human diseases;Biomedicine & Pharmacotherapy;2023-10

4. Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia‐derived neuroinflammation;CNS Neuroscience & Therapeutics;2023-09-04

5. The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD;Journal of Clinical Medicine;2023-05-09